Cytosorbents CorporationCTSONASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-10.12M
↑ 34% vs avg
Percentile
P40
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-15.38M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-10.12M | +31.2% |
| 2024 | $-14.71M | +34.9% |
| 2023 | $-22.59M | +34.9% |
| 2022 | $-34.69M | -89.7% |
| 2021 | $-18.29M | -150.9% |
| 2020 | $-7.29M | +60.1% |
| 2019 | $-18.28M | -47.9% |
| 2018 | $-12.36M | -51.9% |
| 2017 | $-8.14M | -11.1% |
| 2016 | $-7.33M | - |